Related Experiment Video
Updated: May 12, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Melanoma, version 2.2013: featured updates to the NCCN guidelines
Daniel G Coit1, Robert Andtbacka, Christopher J Anker
1Memorial Sloan-Kettering Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|April 16, 2013
Summary
The National Comprehensive Cancer Network (NCCN) updated melanoma treatment guidelines, adding new therapies like ipilimumab and vemurafenib for advanced cases. Recommendations also revised early-stage lesion management and sentinel lymph node biopsy use.
Area of Science:
- Oncology
- Dermatology
- Clinical Practice Guidelines
Background:
- Melanoma management requires up-to-date, evidence-based clinical practice guidelines.
- The National Comprehensive Cancer Network (NCCN) provides comprehensive recommendations for melanoma care.
Purpose of the Study:
- To highlight significant recent updates to the NCCN Guidelines for Melanoma.
- To inform clinicians about advancements in melanoma treatment and diagnostic strategies.
Main Methods:
- Review of recent NCCN Guidelines for Melanoma.
- Inclusion of new therapeutic agents and revised staging and diagnostic protocols.
Main Results:
- Introduction of ipilimumab and vemurafenib for advanced melanoma treatment.
- Inclusion of imatinib for KIT-mutated tumors and pegylated interferon alfa-2b for adjuvant therapy.
- Revisions in early-stage lesion stratification, sentinel lymph node biopsy recommendations, and imaging protocols.
Conclusions:
- The updated NCCN Guidelines offer expanded therapeutic options and refined management strategies for melanoma patients.
- These revisions aim to improve clinical decision-making and patient outcomes in melanoma care.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:19Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...